For the year ending 2025-12-31, LYRA made $398K in revenue. -$28,919K in net income. Net profit margin of -7266.08%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Collaboration revenue | 398 | |||
| Research and development | 18,411 | |||
| General and administrative | 11,540 | |||
| Restructuring and other related charges | 1,469 | |||
| Total operating expenses | 31,420 | |||
| Loss from operations | -31,022 | |||
| Interest income | 1,133 | |||
| Other income | 981 | |||
| Total other income | 2,114 | |||
| Loss before income tax expense | -28,908 | |||
| Income tax expense | 11 | |||
| Net loss | -28,919 | |||
| Comprehensive loss | -28,919 | |||
| Basic EPS | -18.62 | |||
| Diluted EPS | -18.62 | |||
| Basic Average Shares | 1,553,473 | |||
| Diluted Average Shares | 1,553,473 | |||
Lyra Therapeutics, Inc. (LYRA)
Lyra Therapeutics, Inc. (LYRA)